Calamos Wealth Management LLC Cuts Stock Holdings in Veeva Systems Inc. $VEEV

Calamos Wealth Management LLC lessened its stake in Veeva Systems Inc. (NYSE:VEEV) by 13.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,114 shares of the technology company’s stock after selling 2,986 shares during the quarter. Calamos Wealth Management LLC’s holdings in Veeva Systems were worth $5,694,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. ASR Vermogensbeheer N.V. raised its holdings in Veeva Systems by 64.2% in the second quarter. ASR Vermogensbeheer N.V. now owns 5,167 shares of the technology company’s stock valued at $1,488,000 after buying an additional 2,020 shares during the period. Stevens Capital Management LP acquired a new stake in shares of Veeva Systems in the second quarter worth $306,000. Orser Capital Management LLC purchased a new position in shares of Veeva Systems in the 3rd quarter valued at $1,631,000. FORA Capital LLC acquired a new position in shares of Veeva Systems during the 2nd quarter valued at $4,420,000. Finally, QRG Capital Management Inc. lifted its holdings in shares of Veeva Systems by 15.7% during the 2nd quarter. QRG Capital Management Inc. now owns 12,771 shares of the technology company’s stock valued at $3,678,000 after acquiring an additional 1,735 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

VEEV has been the subject of several recent research reports. KeyCorp reiterated a “sector weight” rating on shares of Veeva Systems in a report on Friday, December 12th. Wells Fargo & Company lowered their target price on Veeva Systems from $341.00 to $333.00 and set an “overweight” rating for the company in a research note on Tuesday, November 25th. Needham & Company LLC reissued a “buy” rating and set a $355.00 price target on shares of Veeva Systems in a research report on Friday, November 21st. JPMorgan Chase & Co. upgraded Veeva Systems from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $290.00 to $330.00 in a report on Monday, September 8th. Finally, Barclays lowered their price objective on shares of Veeva Systems from $325.00 to $305.00 and set an “overweight” rating for the company in a research report on Friday, November 21st. Eighteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $307.42.

Veeva Systems Stock Down 0.2%

Shares of NYSE VEEV opened at $224.67 on Wednesday. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The business has a 50 day moving average price of $256.54 and a two-hundred day moving average price of $273.81. The firm has a market cap of $36.93 billion, a PE ratio of 43.71, a price-to-earnings-growth ratio of 1.67 and a beta of 1.05.

Veeva Systems (NYSE:VEEV) last released its earnings results on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, beating the consensus estimate of $1.95 by $0.09. The company had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The business’s revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.75 EPS. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. On average, analysts anticipate that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Insider Transactions at Veeva Systems

In other news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the transaction, the insider owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This trade represents a 12.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the sale, the insider directly owned 25,325 shares of the company’s stock, valued at approximately $7,765,151.50. This represents a 19.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 24,665 shares of company stock valued at $7,438,000. Insiders own 10.30% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.